Lignosulfonic Acid Sodium Is a Noncompetitive Inhibitor of Human Factor XIa
The anticoagulant activity of lignosulfonic acid sodium (LSAS), a non-saccharide heparin mimetic, was investigated in this study. LSAS is a relatively safe industrial byproduct with similar polyanionic characteristics to that of heparin. Human plasma clotting assays, fibrin polymerization testing, a...
Main Authors: | Srabani Kar, Page Bankston, Daniel K. Afosah, Rami A. Al-Horani |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-08-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/14/9/886 |
Similar Items
-
Improved efficacy/safety profile of factor XIa inhibitor BMS‐724296 versus factor Xa inhibitor apixaban and thrombin inhibitor dabigatran in cynomolgus monkeys
by: Pancras C. Wong, et al.
Published: (2021-05-01) -
Synthesis, Docking, and In Vitro Anticoagulant Activity Assay of Hybrid Derivatives of Pyrrolo[3,2,1-<i>ij</i>]Quinolin-2(1<i>H</i>)-one as New Inhibitors of Factor Xa and Factor XIa
by: Nadezhda Novichikhina, et al.
Published: (2020-04-01) -
DISCOVERY AND BIOPHYSICAL CHARACTERIZATION OF ALLOSTERIC INHIBITORS OF FACTOR XIa (FXIa)
by: Argade, Malaika
Published: (2012) -
Designing Direct and Indirect Factor Xa Inhibitors
by: Al-Horani, Rami
Published: (2012) -
Synthetic, Sulfated, Lignin-Based Anticoagulants
by: Mehta, Akul
Published: (2014)